Stage FocusSeed, Series A
GeographyUS, Europe, China, Japan, South Korea, Southeast Asia
TypeCVC
Last Activity2026
Industry Focus
Industries
BiotechMedtech
Technical BenchLimited
Investor TypeCVC
ExposureSome DeepTech Investments
Bio
Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas Pharma, based in South San Francisco. For over 20 years it has made equity investments in privately held, early-stage biotechnology companies developing therapeutic programs and drug-discovery platform technologies, targeting the preclinical stage. Investments are strategic: AVM backs science that either streng...
Notable Investments
S
Solu TherapeuticsD
DeepSeq.AIS
Serna BioSimilar Funds
Boehringer Ingelheim Venture Fund
Ingelheim am Rhein, Germany
GeneralistBiotechMedtechAIPre-SeedSeed
HV
HB Ventures
Shenzhen, China
DeepTech NativeBiotechSemiconductorsQuantumSeedSeries A
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedtechSeedSeries A